Pfizer (PFE) Profit Margin (2008 - 2026)
Pfizer (PFE) profit margin from Jun 29, 2008 to Mar 29, 2026. The current Pfizer (PFE) profit margin is 18.59%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Pfizer (PFE)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 12.42% | -1.62% |
| 2024 | 12.62% | +203.27% |
| 2023 | 4.16% | -87.82% |
| 2022 | 34.18% | +14.50% |
| 2021 | 29.85% | +35.74% |
| 2020 | 21.99% | -43.87% |
| 2019 | 39.18% | +43.41% |
| 2018 | 27.32% | -32.63% |
| 2017 | 40.55% | +196.89% |
| 2016 | 13.66% | -67.98% |
| 2013 | 42.65% | +60.01% |
| 2012 | 26.66% | +62.56% |
| 2011 | 16.40% | +29.42% |
| 2010 | 12.67% | -27.70% |
| 2009 | 17.53% | +4.45% |
| 2008 | 16.78% | -0.24% |
| 2007 | 16.82% | N/A |
Comparison Pfizer (PFE) profit margin with competitors
Pfizer (PFE) profit margin is 18.59%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 50.15% | +169.71% |
| LLY | Lilly(Eli) & Company | 37.36% | +100.93% |
| GILD | Gilead Sciences Inc | 29.04% | +56.18% |
| NVS | Novartis AG | 23.34% | +25.53% |
| BMY | Bristol-Myers Squibb Company | 23.30% | +25.31% |
| GSK | GSK Plc | 22.77% | +22.46% |
| JNJ | Johnson & Johnson | 21.76% | +17.03% |
| AMGN | AMGEN Inc | 21.11% | +13.53% |
| AZN | Astrazeneca plc | 20.15% | +8.37% |
| SNY | Sanofi | 14.35% | -22.82% |
| BIIB | Biogen Inc | 12.89% | -30.68% |
| OGN | Organon & Company | 10.00% | -46.22% |
| ABBV | Abbvie Inc | 4.63% | -75.10% |
| GRFS | Grifols SA | 4.29% | -76.93% |